Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Stem Cell Culture

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...

Somatic to iPS Cell Reprogramming

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for this...

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Predictors of high cost after percutaneous coronary intervention: A review from Japanese multicenter registry overviewing the influence of procedural complications.

American heart journal·2017

Same author

Different indicators for postprocedural mitral stenosis caused by single- or multiple-clip implantation after percutaneous mitral valve repair.

Journal of cardiology·2017

Same author

Progressive Mycotic Celiac Artery Aneurysm Associated With Coagulase-Negative Staphylococcal Prosthetic Valve Endocarditis.

Circulation journal : official journal of the Japanese Circulation Society·2017

Same author

Distinct expression patterns of Flk1 and Flt1 in the coronary vascular system during development and after myocardial infarction.

Biochemical and biophysical research communications·2017

Same author

Transient Collateral Arteries Developed during Coronary Vasospasm.

Internal medicine (Tokyo, Japan)·2017

Same author

[Research and development of therapy for advanced heart failure by utilizing pluripotent stem cell-derived cardiomyocytes].

Nihon yakurigaku zasshi. Folia pharmacologica Japonica·2017

Search research articles

Related Experiment Video

Updated: May 21, 2026

Improved Generation of Induced Cardiomyocytes Using a Polycistronic Construct Expressing Optimal Ratio of Gata4, Mef2c and Tbx5

Improved Generation of Induced Cardiomyocytes Using a Polycistronic Construct Expressing Optimal Ratio of Gata4, Mef2c and Tbx5

Published on: November 13, 2015

Cardiomyocyte generation using stem cells and directly reprogrammed cells.

Masaki Ieda¹, Keiichi Fukuda

¹Department of Clinical and Molecular Cardiovascular Research, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan. mieda@z8.keio.jp

Frontiers in Bioscience (Scholar Edition)

|June 2, 2012

Summary

This summary is machine-generated.

Heart regeneration research explores using stem cells and direct reprogramming to replace damaged cardiomyocytes. Induced pluripotent stem cells and direct conversion offer promising avenues for cardiac repair therapies.

More Related Videos

Generation and Expansion of Human Cardiomyocytes from Patient Peripheral Blood Mononuclear Cells

Generation and Expansion of Human Cardiomyocytes from Patient Peripheral Blood Mononuclear Cells

Published on: February 12, 2021

Assessing Cardiomyocyte Subtypes Following Transcription Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts

Assessing Cardiomyocyte Subtypes Following Transcription Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts

Published on: March 22, 2017

Related Experiment Videos

Last Updated: May 21, 2026

Improved Generation of Induced Cardiomyocytes Using a Polycistronic Construct Expressing Optimal Ratio of Gata4, Mef2c and Tbx5

Improved Generation of Induced Cardiomyocytes Using a Polycistronic Construct Expressing Optimal Ratio of Gata4, Mef2c and Tbx5

Published on: November 13, 2015

Generation and Expansion of Human Cardiomyocytes from Patient Peripheral Blood Mononuclear Cells

Generation and Expansion of Human Cardiomyocytes from Patient Peripheral Blood Mononuclear Cells

Published on: February 12, 2021

Assessing Cardiomyocyte Subtypes Following Transcription Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts

Assessing Cardiomyocyte Subtypes Following Transcription Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts

Published on: March 22, 2017

Area of Science:

Regenerative Medicine
Cardiovascular Biology
Stem Cell Biology

Background:

Cardiomyocytes have limited regenerative capacity, necessitating cell replacement therapies for heart repair.
Embryonic stem (ES) cells and induced pluripotent stem (iPS) cells offer potential for cell replacement due to their pluripotency and expansion capabilities.
Recent advances in iPS cell technology, cardiac differentiation, and purification support stem cell-based cardiac therapies.

Purpose of the Study:

To review recent achievements in stem cell-based cardiac generation.
To discuss challenges in stem cell-based heart regeneration.
To explore direct cardiac reprogramming as a novel therapeutic strategy.

Main Methods:

Utilizing induced pluripotent stem cells (iPSCs) for cardiac differentiation and cell purification.
Investigating direct reprogramming of somatic cells into functional cardiomyocytes.
Employing cardiac transcription factors (Gata4, Mef2c, Tbx5) for direct cell conversion.

Main Results:

Significant progress has been made in iPS cell generation, cardiac differentiation, and purification protocols.
Direct conversion of somatic cells into cardiomyocytes via Gata4, Mef2c, and Tbx5 has been demonstrated.
These advancements pave the way for novel heart regeneration strategies.

Conclusions:

Stem cell-based therapies and direct cardiac reprogramming hold significant promise for treating heart injuries.
Further research is needed to overcome challenges in clinical application and optimize these regenerative approaches.
The development of these technologies represents a major step forward in cardiovascular regenerative medicine.